Osmosis Investment Management UK’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$16.7M Sell
289,321
-265,490
-48% -$15.2M 0.77% 25
2026
Q1
$33.6M Buy
554,811
+94,620
+21% +$5.52M 0.9% 15
2025
Q4
$24.8M Buy
+460,191
New +$22.1M 0.63% 31

Other funds holding BMY

Osmosis Investment Management UK's BMY Position: Q2 2026 in Review

Osmosis Investment Management UK reduced its Bristol-Myers Squibb (BMY) stake by 48% in Q2 2026, selling an estimated $15.2M and leaving 289,321 shares worth $16.7M. The position accounts for 0.77% of the portfolio, ranked #25.

Osmosis Investment Management UK first reported a position in BMY in Q4 2025 and has held it in 3 quarters since. The position peaked at $33.6M in Q1 2026. 2,514 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • Osmosis Investment Management UK held 289,321 shares of Bristol-Myers Squibb worth $16.7M as of Q2 2026.
  • Osmosis Investment Management UK sold 265,490 Bristol-Myers Squibb shares in Q2 2026, an estimated $15.2M.
  • Bristol-Myers Squibb made up 0.77% of Osmosis Investment Management UK's portfolio in Q2 2026, its #25 holding.
  • Osmosis Investment Management UK first reported a position in Bristol-Myers Squibb in Q4 2025 and has held it in 3 quarters since.
  • Osmosis Investment Management UK's Bristol-Myers Squibb position peaked at $33.6M in Q1 2026.
  • 2,514 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Osmosis Investment Management UK's 13F filing for Q2 2026, filed 13 Aug 2026.